Concepedia
Statistics
Publications
27
Citations
1.5K
H-Index
21
Active since
1986
Affiliations
Roche (United States)(Current)
University of Perugia
University of Manchester
Tumour Institute of Tuscany
Boehringer Ingelheim (Italy)
A. Bernareggi is an author at Roche (United States) specializing in pharmacology, pharmacokinetics, and pharmacy.
Publications per year
1986–2018
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 253 citations · Full text
Medicine, Oncology, Pharmacology +9
Physiologic modeling of cyclosporin kinetics in rat and man
A. Bernareggi, Malcolm Rowland · Journal of Pharmacokinetics and Biopharmaceutics · 1991 · 177 citations
Pharmacy, Pharmacokinetics, Pharmacology +12
Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer
Bruce D. Dorsey, Mohamed Iqbal, Sankar Chatterjee et al. · Journal of Medicinal Chemistry · 2008 · 147 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +13
A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules
Alan V. Boddy, E. Ruth Plummer, R Todd et al. · Clinical Cancer Research · 2005 · 108 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +17
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
Cristiana Sessa, Giuseppe Capri, Luca Gianni et al. · Annals of Oncology · 2000 · 76 citations
Pharmacy, Pharmacokinetics, Pharmacology +7
1–5 of 27